Suchergebnisse - "Toes, René"

PubPharm (684)

51

At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2022

von Oskam, N. | Ooijevaar-de Heer, P. | Derksen, N. | +7

52

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

enthalten in: ResearchSquare.com | 2022

von Schaik, M. | Arends, E. | Soonawala, D. | +10

53

Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2022

von Reijm, S. | Brehler, A. | Rantapää-Dahlqvist, S. | +6

54

Multifunctional, Multivalent PIC Polymer Scaffolds for Targeting Antigen-Specific, Autoreactive B Cells

enthalten in: ACS biomaterials science & engineering | 2022

von Kristyanto, H. | Holborough-Kerkvliet, M. | Lelieveldt, L. | +6

55

Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation

enthalten in: Science advances | 2022

von Kissel, T. | Ge, C. | Hafkenscheid, L. | +21

56

Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2022

von Wouters, F. | Maurits, M. | van Boheemen, L. | +9

57

Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA

enthalten in: Annals of the rheumatic diseases | 2022

von Kissel, T. | van Wesemael, T. | Lundquist, A. | +10

58

Hyaluronidase treatment of synovial fluid is required for accurate detection of inflammatory cells and soluble mediators

enthalten in: Arthritis research & therapy | 2022

von Brouwers, H. | von Hegedus, J. | van der Linden, E. | +5

59

Hyaluronidase treatment of synovial fluid is required for accurate detection of inflammatory cells and soluble mediators

enthalten in: Arthritis Research & Therapy | 2022

von Brouwers, H. | von Hegedus, J. | van der Linden, E. | +5

60

Hyaluronidase treatment of synovial fluid is required for accurate detection of inflammatory cells and soluble mediators

enthalten in: Arthritis Research & Therapy | 2022

von Brouwers, H. | von Hegedus, J. | van der Linden, E. | +5